Skip to main content

Regulatory & Access Resources

Browse our regulatory & access resources to find the latest articles, blogs, brochures, and videos from our experts. See the latest content below.

Clinical pharmacology, modeling and simulation to support FIH study design

A major challenge in drug development is the translation of candidate molecules from the preclinical phase to the clinical setting. The key elements to be considered are the pharmacology, toxicology and pharmacokinetic (PK) properties of the candidate molecule, and the quantitative relationships among dose, concentration, target engagement, efficacy, and/or toxicity.